Get started
MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKDMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKDMIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD

MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD

No trades
See on Supercharts
Overview
Analysis
Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪309.80 M‬ HKD
Fund flows (1Y)
‪−117.41 M‬ HKD
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.8%
Shares outstanding
‪6.95 M‬
Expense ratio
0.68%

About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD


Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Home page
globalxetfs.com.hk
Inception date
Jul 25, 2019
Index tracked
Solactive China Biotech Index - CNY - Benchmark TR Net
Replication method
Physical
Management style
Passive
Distributes
Capital Gains
Primary advisor
Mirae Asset Global Investments (Hong Kong) Ltd.
ISIN
HK0000516697
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of January 27, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Cash
Stocks54.77%
Health Technology52.23%
Bonds, Cash & Other45.22%
Cash50.09%
Miscellaneous−4.87%
Stock breakdown by region
6%93%
Asia93.27%
North America6.73%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows